Stockholders Deficit (Tables)

9 Months Ended

Sep. 30, 2020

Equity [Abstract]

Summary of Stock Option Plans Activity

A summary of the Company’s stock option activity for the nine months ended September 30, 2020 is as follows:

	Number of Shares			Weighted- Average Exercise Price Per Share		Weighted- Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value
Balance at December 31, 2019		2,904,898		$	2.37		8.0	$	781
Granted		5,766,000			0.52
Exercised		-			-			$	-
Forfeited		(1,102,897	)		1.01
Expired/Cancelled		(82,512	)		3.29
Balance at September 30, 2020		7,485,489		$	1.13		8.9	$	404
Exercisable at September 30, 2020		2,489,579		$	1.98		7.4	$	101

Summary of Restricted Stock Unit ("RSU") Award Activity

The following table summarizes restricted stock unit (“RSU”) award activity for the nine months ended September 30, 2020:

	Number of Shares			Weighted- Average Grant Date Fair Value Per Share
Balance at December 31, 2019		223,745		$	2.91
Granted		105,000			0.52
Released		(97,819	)		2.43
Forfeited		(26,875	)		2.75
Balance at September 30, 2020		204,051		$	1.94
Vested and unissued at September 30, 2020		20,783		$	2.21

Summary of Stock-Based Compensation Recorded in the Condensed Consolidated Statements of Operations

Stock-based compensation expense recorded in the accompanying condensed consolidated statements of operations for the three and nine months ended September 30, 2020 and 2019 was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Selling, general and administrative	$	380,676	$	226,645	$	1,070,651	$	625,821
Research and development		884		74,652		81,374		181,336
Cost of product and product-related services revenue		5,389		15,258		11,717		37,976
	$	386,949	$	316,555	$	1,163,742	$	845,133